معرفی
Terence O'Brien is a Professor of Neuroscience at Monash University, serving as Chair of Medicine (Neurology) and Head of the School of Translational Medicine. He holds roles such as Program Director of Alfred Brain and Deputy Director of Research at Alfred Health. His career includes former positions like Van Cleef Roet Chair of Neuroscience (2017-2020) and James Stewart Chair of Medicine at the University of Melbourne (2008-2017). He trained at St. Vincent’s Hospital, Royal Melbourne Hospital, and the Mayo Clinic.
Education and Clinical Background: Clinical and research training at St. Vincent’s and Royal Melbourne Hospitals, followed by advanced training at the Mayo Clinic (1995-1998). Served as Immediate Past President of the Epilepsy Society of Australia.
Research Interests: Focuses on epilepsy, neurodegenerative diseases, neuropharmacology, and translational research. Key contributions include developing the SISCOM imaging technique for epilepsy surgery, leading the Australian Pregnancy Register on antiseizure medications, and pioneering bioengineering devices for neurological disorders. His work spans preclinical drug development, clinical trials, and neuroimaging innovations.
Articles Trends: Recent publications emphasize biomarkers in traumatic brain injury, personalized epilepsy treatment protocols, and neurodegenerative mechanisms. Key themes include precision medicine, epilepsy surgery outcomes, and translational neurotechnology.
- Awards: 18 international awards, including the James Lance Oration (2023), Fritz E. Dreifuss Lecture (2022), and Ambassador for Epilepsy Award (2017).
Advising & Grants: Supervised 58 PhD students, 11 masters students, and numerous postdoctoral researchers. Currently mentoring 20 PhD candidates and 14 postdoctoral fellows. Leads over 134 active or completed projects, including clinical trials for BHV-7000 and CB03-154 in epilepsy.
Labs/Teams: Directs the O’Brien Group at Monash University, focusing on translational neuroscience. Collaborates internationally in epilepsy research and clinical trials.
